Статті-сироти
На такі сторінки нема посилань з інших сторінок і вони не включаються до інших сторінок HistoryPedia.
Нижче показано до 50 результати у діапазоні від #11 до #60.
Переглянути (попередні 50 • наступні 50) (20 • 50 • 100 • 250 • 500).
- (-)-p-Bromotetramisole Oxalate Enjoys Free Turbocharge... Through A Social Act Institution!
- (-)-p-Bromotetramisole Oxalate Marketers Are Now Being Buzzed In The Us, Not Only The European Countries
- (1999) in which the participants in these research had been described as giving
- (1999) in which the participants in these research were described as offering
- (1999) in which the participants in these studies had been described as offering
- (1999) in which the participants in these studies had been described as providing
- (1999) in which the participants in these studies had been described as supplying
- (1999) in which the participants in these studies have been described as offering
- (1999) in which the participants in these studies have been described as supplying
- (1999) in which the participants in those research had been described as giving
- (1999) in which the participants in those research had been described as offering
- (1999) in which the participants in those research have been described as supplying
- (1999) in which the participants in those studies had been described as giving
- (1999) in which the participants in those studies had been described as providing
- (1999) in which the participants in those studies have been described as delivering
- (1999) in which the participants in those studies have been described as offering
- (1999) in which the participants in those studies were described as giving
- (2015), we postulate that geographic distance serves as a normally reputable proxy
- (80.45 ) and 17 individuals 6 points (19.55 ). 5 individuals (five.74 ) created liver decompensation during antiviral therapy.
- (80.45 ) and 17 individuals 6 points (19.55 ). 5 patients (5.74 ) developed liver decompensation in the course of antiviral therapy.
- (80.45 ) and 17 individuals 6 points (19.55 ). 5 sufferers (5.74 ) created liver decompensation for the duration of antiviral therapy.
- (80.45 ) and 17 individuals six points (19.55 ). 5 individuals (5.74 ) developed liver decompensation in the course of antiviral therapy.
- (80.45 ) and 17 individuals six points (19.55 ). 5 individuals (five.74 ) developed liver decompensation for the duration of antiviral therapy.
- (80.45 ) and 17 individuals six points (19.55 ). Five individuals (5.74 ) created liver decompensation for the duration of antiviral therapy.
- (80.45 ) and 17 patients 6 points (19.55 ). 5 individuals (5.74 ) developed liver decompensation in the course of antiviral therapy.
- (80.45 ) and 17 patients 6 points (19.55 ). Five individuals (five.74 ) developed liver decompensation in the course of antiviral therapy.
- (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (5.74 ) created liver decompensation during antiviral therapy.
- (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (5.74 ) developed liver decompensation in the course of antiviral therapy.
- (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (five.74 ) created liver decompensation in the course of antiviral therapy.
- (80.45 ) and 17 patients six points (19.55 ). 5 patients (five.74 ) created liver decompensation through antiviral therapy.
- (80.45 ) and 17 patients six points (19.55 ). 5 sufferers (5.74 ) developed liver decompensation in the course of antiviral therapy.
- (80.45 ) and 17 patients six points (19.55 ). Five sufferers (five.74 ) created liver decompensation for the duration of antiviral therapy.
- (80.45 ) and 17 sufferers 6 points (19.55 ). 5 sufferers (five.74 ) developed liver decompensation during antiviral therapy.
- (80.45 ) and 17 sufferers 6 points (19.55 ). Five patients (5.74 ) developed liver decompensation during antiviral therapy.
- (80.45 ) and 17 sufferers 6 points (19.55 ). Five sufferers (five.74 ) created liver decompensation for the duration of antiviral therapy.
- (A) Stomatal closure in wild kind Col- (white bars) and ahk5-one (black bars) leaves 2.five h soon after exposure to escalating concentrations of H2O2
- (E) Step three uses the Gamma parameter plane spanned by the shape
- (F) Estimation of the number of viable cells at 48 and 96 h in P19 cells taken care of with .32 M CsA throughout EB formation
- (Figure 1D). Infections with strains carrying welldefined mutations identified to exclusively
- (GenBank accession no. DQ389174), which was reported to have low identity
- (GenBank accession no. DQ389174), which was reported to possess low identity
- (N = 37), such as those encoding 13 protein
- (Table 1). We developed a extremely sensitive search tactic combining key terms
- (UNCH-A section) and represented by the socalledRhino-SandsofDaxner-H ketal.(2017,thisissue).The correlation
- (along with the BDFE) of tBu3PhOH.40 The EPR equilibration process supplies
- (as well as the BDFE) of tBu3PhOH.40 The EPR equilibration method offers
- (aspect 1 = three.96 and factor 2 = 1.82). The two-factor structure was consistent with our theoretical
- (mean of 3 set of experiments) in induced nNOS mRNA (column AAV
- (sd 5 five.3). Age of onset at Wave three was obtained in two techniques
- ), CKD (N = 261), cardiovascular (N = 578), diabetes (N = 857) and respiratory groups (N = 1156) d
Переглянути (попередні 50 • наступні 50) (20 • 50 • 100 • 250 • 500).